Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck gains NASH candidate from NGM Biopharmaceuticals

pharmaceutical-technologyJanuary 08, 2019

Tag: monoclonal antibody , Merck , NGM313 , NASH , NGM Biopharmaceuticals

PharmaSources Customer Service